Literature DB >> 23798433

Interfering with Gal-1-mediated angiogenesis contributes to the pathogenesis of preeclampsia.

Nancy Freitag1, Irene Tirado-González, Gabriela Barrientos, Florian Herse, Victor L J L Thijssen, Susanne M Weedon-Fekjær, Herbert Schulz, Gerd Wallukat, Burghard F Klapp, Tania Nevers, Surendra Sharma, Anne Cathrine Staff, Ralf Dechend, Sandra M Blois.   

Abstract

Preeclampsia (PE) is a pregnancy-specific disorder characterized by sudden onset of hypertension and proteinuria in the second half of pregnancy (>20 wk). PE is strongly associated with abnormal placentation and an excessive maternal inflammatory response. Galectin-1 (Gal-1), a member of a family of carbohydrate-binding proteins, has been shown to modulate several processes associated with placentation and to promote maternal tolerance toward fetal antigens. Here, we show that Gal-1 exhibits proangiogenic functions during early stages of pregnancy, promoting decidual vascular expansion through VEGF receptor 2 signaling. Blocking Gal-1-mediated angiogenesis or lectin, galactoside-binding, soluble, 1 deficiency results in a spontaneous PE-like syndrome in mice, mainly by deregulating processes associated with good placentation and maternal spiral artery remodeling. Consistent with these findings, we observed a down-regulation of Gal-1 in patients suffering from early onset PE. Collectively, these results strengthen the notion that Gal-1 is required for healthy gestation and highlight Gal-1 as a valuable biomarker for early PE diagnosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23798433      PMCID: PMC3710834          DOI: 10.1073/pnas.1303707110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Anginex, a designed peptide that inhibits angiogenesis.

Authors:  A W Griffioen; D W van der Schaft; A F Barendsz-Janson; A Cox; H A Struijker Boudier; H F Hillen; K H Mayo
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

Review 2.  Preeclampsia: an excessive maternal inflammatory response to pregnancy.

Authors:  C W Redman; G P Sacks; I L Sargent
Journal:  Am J Obstet Gynecol       Date:  1999-02       Impact factor: 8.661

Review 3.  The biology of vascular endothelial growth factor.

Authors:  N Ferrara; T Davis-Smyth
Journal:  Endocr Rev       Date:  1997-02       Impact factor: 19.871

4.  Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor.

Authors:  G Wallukat; V Homuth; T Fischer; C Lindschau; B Horstkamp; A Jüpner; E Baur; E Nissen; K Vetter; D Neichel; J W Dudenhausen; H Haller; F C Luft
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

5.  Differential expression of two beta-galactoside-binding lectins in the reproductive tracts of pregnant mice.

Authors:  B Phillips; K Knisley; K D Weitlauf; J Dorsett; V Lee; H Weitlauf
Journal:  Biol Reprod       Date:  1996-09       Impact factor: 4.285

Review 6.  Abnormal placentation and the syndrome of preeclampsia.

Authors:  Michael T McMaster; Yan Zhou; Susan J Fisher
Journal:  Semin Nephrol       Date:  2004-11       Impact factor: 5.299

7.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

8.  Quantitative analysis of trophoblast invasion in preeclampsia.

Authors:  Thajasvarie Naicker; Shaun M Khedun; Jagidesa Moodley; Robert Pijnenborg
Journal:  Acta Obstet Gynecol Scand       Date:  2003-08       Impact factor: 3.636

9.  Prenatal detection of ischemic changes in the placenta of the growth-retarded fetus by Doppler flow velocimetry of the maternal uterine artery.

Authors:  M Iwata; N Matsuzaki; I Shimizu; N Mitsuda; M Nakayama; N Suehara
Journal:  Obstet Gynecol       Date:  1993-10       Impact factor: 7.661

Review 10.  Recent Insights into the pathogenesis of pre-eclampsia.

Authors:  J M Roberts; K Y Lain
Journal:  Placenta       Date:  2002-05       Impact factor: 3.481

View more
  36 in total

1.  Regulation of Blood Pressure by Targeting CaV1.2-Galectin-1 Protein Interaction.

Authors:  Zhenyu Hu; Guang Li; Jiong-Wei Wang; Suet Yen Chong; Dejie Yu; Xiaoyuan Wang; Jia Lin Soon; Mui Cheng Liang; Yuk Peng Wong; Na Huang; Henry M Colecraft; Ping Liao; Tuck Wah Soong
Journal:  Circulation       Date:  2018-10-02       Impact factor: 29.690

Review 2.  A potential pathophysiological role for galectins and the renin-angiotensin system in preeclampsia.

Authors:  Sandra M Blois; Ralf Dechend; Gabriela Barrientos; Anne Cathrine Staff
Journal:  Cell Mol Life Sci       Date:  2014-09-06       Impact factor: 9.261

Review 3.  Evolving mechanistic insights into galectin functions.

Authors:  Connie M Arthur; Marcelo Dias Baruffi; Richard D Cummings; Sean R Stowell
Journal:  Methods Mol Biol       Date:  2015

Review 4.  Galectins in tumor angiogenesis.

Authors:  Arjan W Griffioen; Victor L Thijssen
Journal:  Ann Transl Med       Date:  2014-09

Review 5.  Prediction of preeclampsia-bench to bedside.

Authors:  Anjali Acharya; Wunnie Brima; Shivakanth Burugu; Tanvi Rege
Journal:  Curr Hypertens Rep       Date:  2014-11       Impact factor: 5.369

Review 6.  Canonical and noncanonical vascular endothelial growth factor pathways: new developments in biology and signal transduction.

Authors:  Courtney K Domigan; Safiyyah Ziyad; M Luisa Iruela-Arispe
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-10-02       Impact factor: 8.311

Review 7.  Resolution of inflammation pathways in preeclampsia-a narrative review.

Authors:  Luiza Oliveira Perucci; Mário Dias Corrêa; Luci Maria Dusse; Karina Braga Gomes; Lirlândia Pires Sousa
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

8.  Glycan characterization of pregnancy-specific glycoprotein 1 and its identification as a novel Galectin-1 ligand.

Authors:  Mirian Mendoza; Dongli Lu; Angela Ballesteros; Sandra M Blois; Kelsey Abernathy; Chiguang Feng; Charles J Dimitroff; Jonathan Zmuda; Maria Panico; Anne Dell; Gerardo R Vasta; Stuart M Haslam; Gabriela Dveksler
Journal:  Glycobiology       Date:  2020-10-21       Impact factor: 4.313

9.  Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression.

Authors:  Dong Tang; Jun Gao; Sen Wang; Nianyuan Ye; Yang Chong; Yuqin Huang; Jie Wang; Bin Li; Wei Yin; Daorong Wang
Journal:  Tumour Biol       Date:  2015-09-01

10.  Galectin-1 interacts with the human endogenous retroviral envelope protein syncytin-2 and potentiates trophoblast fusion in humans.

Authors:  Caroline Toudic; Amandine Vargas; Yong Xiao; Guillaume St-Pierre; Norbert Bannert; Julie Lafond; Éric Rassart; Sachiko Sato; Benoit Barbeau
Journal:  FASEB J       Date:  2019-09-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.